ABVC BioPharma, Inc. (ABVC) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 中性 — 1 持有.
分析师预估 每股收益(EPS)为 $-4.40 和 营收为 $0.02B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.43 vs 预期 $-4.40 (超预期 +90.2%). 2025: 实际 $-0.39 vs 预期 $-4.60 (超预期 +91.5%). 分析师准确度: 0%.
ABVC 分析师评级
Hold
基于过去3个月内 1 位分析师对 ABVC BioPharma, Inc. 的评级
EPS 预测 — ABVC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.43
vs Est –$4.40
▲ 923.3% off
2025
Actual –$0.39
vs Est –$4.60
▲ 1,079.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — ABVC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.001B
vs Est $0.015B
▼ 2,748.2% off
2025
Actual $0.001B
vs Est $0.004B
▼ 424.3% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
